OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
20
Results
Show all
Save search
Copy query
Show results for
Unknown
(20)
Release Date
2021
(5)
2022
(4)
2020
(4)
2025
(3)
2023
(2)
2024
(1)
2017
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Genome-wide association analysis and replication in 810,625 individuals with varicose veins.
Not available
S-EPMC9163161
|
biostudies-literature
Cite
Genome-wide Study Identifies Association between HLA-B
∗
55:01 and Self-Reported Penicillin Allergy.
Not available
S-EPMC7536643
|
biostudies-literature
Cite
Identification of novel risk loci for restless legs syndrome in genome-wide association studies in individuals of European ancestry: a meta-analysis.
Not available
S-EPMC5755468
|
biostudies-literature
Cite
Genomic analysis of male puberty timing highlights shared genetic basis with hair colour and lifespan.
Not available
S-EPMC7093467
|
biostudies-literature
Cite
Inherited myeloproliferative neoplasm risk affects haematopoietic stem cells.
Not available
S-EPMC7606745
|
biostudies-literature
Cite
Risk of Bowel Obstruction in Patients Undergoing Neoadjuvant Chemotherapy for High-risk Colon Cancer: A Nested Case-control-matched Analysis of an International, Multicenter, Randomized Controlled Trial (FOxTROT).
Not available
S-EPMC11224564
|
biostudies-literature
Cite
Genome-wide meta-analysis identifies 127 open-angle glaucoma loci with consistent effect across ancestries.
Not available
S-EPMC7904932
|
biostudies-literature
Cite
Plasma AR Alterations and Timing of Intensified Hormone Treatment for Prostate Cancer: the STAMPEDE Phase 3 Randomized Clinical Trial.
Not available
S-EPMC11869088
|
biostudies-literature
Cite
Metformin for patients with metastatic prostate cancer starting androgen deprivation therapy: a randomised phase 3 trial of the STAMPEDE platform protocol.
Not available
S-EPMC12303861
|
biostudies-literature
Cite
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8084355
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets